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Abstract  Breast  inﬂammation  is  a  difﬁcult  clinical  problem  as  it  can  result  from  a  variety
of causes:  speciﬁc  or  non-speciﬁc  infectious  mastitis,  which  may  or  may  not  be  complicated,
primary or  secondary  inﬂammatory  mastitis  or  inﬂammatory  cancer.  The  main  objective  of
radiology  is  to  eliminate  an  inﬂammatory  cancer.  Other  objectives  are  to  characterise  an  inﬂam-
matory condition  (where  the  clinical  context  is  valuable  in  guiding  diagnosis  but  which  often
requires a  micro-  or  macrobiopsy)  or  to  obtain  a  microorganism  in  cases  of  complicated  infec-
tious mastitis  (a  diagnostic  procedure  but  also  comprising  the  ﬁrst  stage  of  treatment).  Whether
for bacteriological  or  histological  purposes,  percutaneous  samples  therefore  play  a  large  part
in the  diagnostic  procedure,  other  than  in  the  clinical  context  of  pregnancy  where  mastitis  is
more easily  diagnosed  because  of  its  frequency.  The  guidance  method  is  usually  ultrasound,
and the  needle  chosen  will  depend  on  the  radiological  or  ultrasound  signal:  puncture  with  an
18G needle  will  be  used  for  a  bacteriological  sample,  microbiopsy  of  a  mass  or  lymph  nodes,  or
macrobiopsy  in  the  case  of  microcalciﬁcations.
© 2011  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
The  incidence  of  benign  and  malignant  inﬂammatory  breast  conditions  is  growing.
Breast  inﬂammation  can  be  the  result  of  various  causes  including  infectious  mastitis,
inﬂammatory  mastitis  or  inﬂammatory  cancer.  Since  the  principal  aim  in  these  cases
is  to  eliminate  inﬂammatory  cancer,  biopsies  are  widely  indicated,  assisted  by  imaging
techniques.  The  next  objectives,  once  inﬂammatory  cancer  has  indeed  been  eliminated,
are  to  characterise  a  non-infectious  mastitis,  followed,  in  the  case  of  an  abscess,  by
obtaining  a  microorganism.  Taking  bacteriological  samples  actually  includes  the  ﬁrst  stage
of  treatment,  as  will  be  seen  later.
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Boxed  text  1  Causes  of  symptoms  of  breast
inﬂammation.
1.  Infectious  mastitis
• Simple  mastitis
•  An  abscess:
◦ periareolar;
◦  peripheral;
◦  complicating  a  mammary  (galactocoele)  or
dermal  lesion.
• Speciﬁc  mastitis:
◦ tuberculosis;
◦ actinomycosis,  blastomycosis;
◦  ﬁlariasis.
2. Non-infectious  mastitis
•  Primary  mastitis:
◦  duct  ectasia,  periductal  mastitis,  plasma  cell
mastitis;
◦  granulomatous  lobular  mastitis.
•  Secondary  mastitis:
◦  a  complication  of  surgery/radiotherapy;
◦  immunological  causes:
—  diabetes,
—  systemic  disease  (Churg-Strauss,  Wegener,
sarcoidosis,  lupus,  amyloidosis);
◦  vascular  causes:
— superﬁcial  venous  thrombosis  (Mondor’s
disease).
3. Cancer
• Inﬂammatory  breast  cancer
• Other:  lymphoma,  metastasis,  sarcoma
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Non-infectious mastitisA variety of causes
The  signiﬁcance  of  the  clinical  symptoms  of  breast  inﬂam-
mation,  i.e.  redness,  heat  and  possibly  pain,  is  not
speciﬁc  and  may  be  related  to  any  of  the  three  main
aetiological  situations:  infection,  inﬂammation  or  tumour
(Boxed  text  1  ).
Infectious mastitis
Infectious  mastitis  may  be  simple  or  complicated  by
abscesses.  These  abscesses  may  also  complicate  mammary
cysts,  sebaceous  cysts  or  galactocoeles.
Simple  mastitis
Infectious  mastitis  is  more  frequent  in  young  patients  under
the  age  of  40  during  the  breast-feeding  or  post-partum
period.  Clinical  systems  consist  of  erythema,  an  increase
in  skin  temperature  and  the  spontaneous  sensitivity  of  the
breast  increased  on  palpation.  In  general,  it  appears  in  less
than  48  hours,  frequently  with  pain,  which  may  be  intense
and  is  generally  not  associated  with  either  skin  thickening
or  a  palpable  mass.  The  symptoms  disappear  rapidly  in  less
than  10  days  with  suitable  antibiotic  treatment.
M
c117
astitis  complicated  by  an  abscess
astitis  during  lactation  is  frequently  complicated  by
bscesses,  which  generally  occur  within  the  3  months  fol-
owing  the  birth  [1].  They  are  more  common  in  primiparous
atients  and  respond  well  to  antibiotics.
Non-pregnancy  related  abscesses  are  encouraged  by  obe-
ity,  diabetes  and  above  all  the  use  of  tobacco.  They  are
ore  common  in  black  patients.  Periareolar  abscesses  must
e  differentiated  from  peripheral  or  deep  abscesses  [1]:
periareolar  abscesses  occur  most  frequently.  From  a  phys-
iopathological  point  of  view,  they  involve  malpighian
metaplasia  of  the  epithelium  of  the  wall  of  the  lactif-
erous  sinus,  with  desquamation  obstructing  the  lumen.
This  results  in  mastitis  followed  by  an  abscess,  with  ﬁs-
tula  tracts  developing  that  reach  the  periareolar  region.
This  type  of  abscess  very  frequently  recurs.  The  cause
is  a  microorganism,  with  staphylococci,  streptococci  and
anaerobic  bacteria  in  decreasing  order  of  causation  but
with  a considerable  number  of  infections  being  polybacte-
rial.  Nipple  inversion  could  encourage  this  type  of  abscess.
The  main  factor  acknowledged  to  encourage  them  is
tobacco,  possibly  through  its  having  a  toxic  effect  on  the
epithelium  of  the  retroareolar  milk  ducts;
peripheral  abscesses  complicating  mastitis  are  less  com-
mon.  They  occur  in  older  patients  and  are  encouraged
by  diabetes,  rheumatoid  arthritis,  corticosteroids  and
recent  surgery.  Staphylococci  are  the  most  frequently
encountered  agents  but  streptococci  and  anaerobic
microorganisms  may  also  be  responsible.  The  response  to
antibiotics  is  good  with  a  low  rate  of  recurrence.
More  rarely,  an  abscess  may  complicate  a  skin  lesion  (an
pidermoid  cyst)  or  a  breast  lesion  (a  mammary  cyst,  galac-
ocoele,  cytosteatonecrosis  focus  or  postoperative  seroma).
n  a  series  of  197  consecutive  patients  with  clinical  symp-
oms  of  mastitis,  a secondarily  infected  cyst  or  a  secondarily
nfected  postoperative  abscess,  both  of  which  produce
he  appearance  on  an  ultrasound  image  of  a thick-walled
bscess,  was  responsible  for  the  inﬂammatory  symptoms
n  9.2%  and  7.5%,  respectively,  of  patients  included  in  the
eries  [2].
peciﬁc  infectious  mastites
hese  speciﬁc  infections  may  be  related  to  a  mycobac-
erium,  a  fungus  or  a  parasite.  They  are  rare  and  induce
 granulomatous  inﬂammatory  reaction.  Tuberculous  mas-
itis  is  encountered  in  developing  countries  or  in  patients
nfected  by  the  HIV  virus.  Infection  reaches  the  breast  via  a
etrograde  pathway  from  the  axillary  lymph  nodes,  or  more
arely  via  the  cervical  or  parasternal  nodes.  A  blood-borne
oute  is  rarer  and  is  encountered  mainly  in  HIV  patients.
Fungal  infections  such  as  actinomycosis  (Fig.  1)  and  blas-
omycosis  may  result  in  mammary  involvement.
The  parasitic  infection  ﬁlariasis,  with  its  very  speciﬁc
ymptoms  of  serpiginous  microcalciﬁcations  often  associ-
ted  with  a  mass,  can  be  easily  diagnosed  by  mammography.astitis  may  be  caused  by  a  certain  number  of  immunologi-
al  or  vascular  inﬂammatory  lesions.
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Figure 1. Patient aged 72, with no personal or family history of breast risk. Right inferior medial inﬂammatory mass which has been
evolving over several weeks. a: Breast MRI: axial T2 TSE; b: breast MRI: axial T1 EG 3D, subtraction at the third minute. Right inferior medial
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sbscessed mass (arrow) with thick, enhanced wall. Ultrasound-gu
olonies (A) in the form of a ﬁlamentous mass, associated with a po
uct  ectasia  and  plasma  cell  mastitis
uct  ectasia,  periductal  mastitis  and  plasma  cell  mastitis
re  different  evolutionary  stages  of  a  single  disease.  Duct
ctasia  is  found  in  a  peri-  or  retroareolar,  often  bilateral,
ocation,  typically  characterised  on  a  mammogram  by  long,
hick,  linear  calciﬁcations  in  the  milk  ducts.  Duct  secre-
ions  may  extravasate  into  the  connective  tissue,  causing
lasma  cell  mastitis.  In  the  periductal  connective  tissue,
hese  secretions  behave  like  a  foreign  body,  resulting  in  the
ormation  of  inﬂammatory  granulomas,  without  necrosis  but
ith  inﬁltrates  of  histiocytes,  lymphocytes,  plasma  cells  and
iant  cells  [3].  In  this  form  of  mastitis,  the  clinical  symptoms
nd  ultrasound  signs  are  found  in  juxta-  and  retroareolar
ocations,  often  associated  with  nipple  retraction.  This  dis-
ase  is  the  prime  cause  of  inﬂammatory  mastitis  (accounting
or  40  of  the  54  cases  of  inﬂammatory  mastitis  identiﬁed  in
he  Egyptian  series  mentioned  above  [2]).nﬂammatory  mastitis  complicating  surgery
astitis  after  radiosurgical  treatment  of  breast  cancer  is  a
requent  form  of  non-infectious  mastitis.  In  general,  there
s  no  solid  mass  with  individual  characteristics  seen  by
e
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tmicrobiopsy showed actinomycosis of the breast; c: actinomyces
rphonuclear neutrophil (PNN) inﬁltrate.
ltrasound or  MRI,  and  the  problem  lies  in  distinguishing  this
astitis  from  a  recurrence  of  the  tumour.
astitis  of  immunological  origin
iabetic  mastitis  is  the  most  typical  of  this  type  of  masti-
is;  it  occurs  in  nearly  10%  of  non-insulin-dependent,  young
iabetic  patients  [4].  It  often  appears  as  a  painful  mass,
ometimes  with  inﬂammatory  symptoms,  which  is  often  mul-
icentric,  bilateral  and  mobile  but  hard  on  palpation.  Based
n  these  clinical  features  alone,  it  is  suspect.  It  has  an
uto-immune  aetiology,  with  perilobular  and  perivascular
ymphocyte  inﬁltration  combined  with  ﬁbrosis  and  lobular
trophy.  The  mechanism  and  lymphocyte  inﬁltration  are  the
ame  as  that  encountered  in  other  lesions  affecting  other
lands,  such  as  Sjögren’s  syndrome  in  the  salivary  glands,  or
ashimoto’s  thyroiditis  in  the  thyroid.
Breast  involvement  with  an  immunological  origin  can  be
ncountered  in  other  diseases  [5]  such  as:  Churg-Strauss
yndrome,  which  combines  asthma,  pulmonary  inﬁltrates,
osinophilia  and  systemic  vasculitis;  amyloidosis,  in  which
reast  inﬁltration  is  rare  and  late;  Wegener’s  granulomato-
is,  which  is  necrotising  vasculitis  affecting  the  respiratory
ract,  kidneys,  skin,  muscles,  joints  and  the  peripheral
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nervous  system,  exceptionally  with  breast  involvement;  sar-
coidosis,  which  affects  the  lungs,  lymph  nodes,  skin,  spleen
and  liver,  and,  again,  the  breast,  rarely  but  in  a  manner
which  is  occasionally  very  revealing.
Inﬂammatory  breast  diseases  of  undetermined
aetiology
Lobular  granulomatous  mastitis,  although  uncommon  (only
1%  of  cases  in  the  Egyptian  series  [2]),  needs  to  be  recog-
nised.  It  occurs  in  young  women  often  within  5  years  of
childbirth.  It  is  diagnosed  by  exclusion  [6]:  it  is  not  gran-
ulomatosis  secondary  to  a  disease  such  as  sarcoidosis,
Wegener’s  granulomatosis  or  tuberculosis.  Nor  is  there  any
trauma,  foreign  body  or  speciﬁc  infection.  The  inﬂamma-
tory  clinical  symptoms  are  very  inconsistent  (encountered
in  11%  of  cases  in  a  series  of  54  patients  [7]),  but  a  number
of  patients  tell  of  a  history  of  prior  incision  and  drainage,
of  symptoms  developing  over  several  months  despite  tak-
ing  antibiotics.  In  practice,  there  is  no  clear  pattern  of
clinical,  mammographic  or  ultrasound  symptoms  and  it  is
biopsies  that  produce  the  diagnosis,  even  when  an  ultra-
sound  image  of  a  poorly  circumscribed  mass  composed  of
hypoechoic  tubular  formations  seems  to  suggest  this  condi-
tion  [7].  It  is  important  to  diagnose  this  disease  because  it
can  be  effectively  treated  with  corticosteroids.
Mondor’s  disease
Mondor’s  disease  is  a  rare  disease  involving  thrombophlebitis
limited  to  the  sub-cutaneous  veins  of  the  breast  [5].  Clinical
diagnosis  involves  ﬁnding  a  palpable,  painful,  tense  band,
generally  occurring  in  the  lateral  quadrants  of  the  breast.
Ultrasound  examination  conﬁrms  the  diagnosis  showing  a
thrombosed  vein  at  the  site  of  the  painful  band.
Inﬂammatory cancers
Inﬂammatory  cancers  are  the  most  aggressive  form  of  breast
cancer  and  are  responsible  for  1  to  5%  of  such  cancers
[8,9].  In  December  2008,  a  panel  of  experts  met  in  Hous-
ton  to  establish  diagnostic  and  therapeutic  criteria  for  these
inﬂammatory  cancers.  This  group’s  conclusions  have  been
recently  published  [10]. The  diagnostic  criteria  are  clinical
and  histopathological.  The  clinical  criteria  are  breast  ery-
thema  covering  at  least  one  third  of  the  breast,  oedema
and/or  an  orange-peel  appearance  of  the  skin,  a  hot  breast,
with  or  without  a  palpable  mass,  these  clinical  symptoms
all  developing  within  less  than  6  months.  The  histopatholog-
ical  criterion  is  conﬁrmation  of  an  invasive  cancer.  Vascular
emboli  are  frequently  found  in  the  superﬁcial  dermis.  Nev-
ertheless,  contrary  to  what  has  been  previously  established,
this  is  not  an  absolute  diagnostic  criterion  of  inﬂammatory
cancer:  dermal  involvement  may  be  absent  in  more  than
one  case  in  ﬁve  of  inﬂammatory  cancer,  but  conversely,  the
presence  of  such  emboli  in  the  absence  of  clinical  signs  of
inﬂammation  does  not  conﬁrm  inﬂammatory  cancer.
Inﬂammatory  cancers  must  be  distinguished  from  locally
advanced  breast  cancers  and  secondary  inﬂammation  of
breast  cancers.  To  take  into  account  the  concept  of  evolving
inﬂammatory  signs  or  ‘poussées  évolutives’,  the  Insti-
tut  Gustave-Roussy  [11]  has  established  PEV  classiﬁcation,
which  is  based  on  the  clinical  data  and  helps  differentiate
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rue  inﬂammatory  cancers  from  secondary  inﬂammation  of
reast  cancers.  Cancers  classed  as  PEV  1  are  tumours  devel-
ping  over  the  previous  2  months,  without  inﬂammatory
igns.  Cancers  classed  as  PEV  2  are  palpable  masses  with
umour  inﬂammation  plus  skin  inﬂammation  involving  less
han  half  of  the  breast,  which  have  developed  over  more
han  4  months.  PEV  3  cancers  are  palpable  masses  with
eritumoural  inﬂammation  plus  skin  inﬂammation  involving
ore  than  half  of  the  breast,  which  have  developed  in  less
han  4  months.  Strictly  speaking,  only  PEV  3s  are  inﬂamma-
ory  cancers.  Inﬂammatory  cancer  is  an  aggressive  cancer
ften  affecting  both  breasts  but,  above  all,  with  metastasis
ound  in  30%  of  patients  at  the  time  of  diagnosis.  The  prog-
osis  for  these  cancers  is  poor,  with  mean  survival  of  3  to
 years.
In addition  to  inﬂammatory  breast  cancer,  a  number  of
eoplastic  breast  diseases,  which  are  not  adenocarcinomas,
ay  present  with  inﬂammation:  cutaneous  or  intramam-
ary  metastasis,  and  sarcomas,  including  angiosarcoma,
elanoma,  and  non-Hodgkin’s  lymphoma,  for  which  clinical
nﬂammation  is  classic  but,  in  reality,  rare  [12,13].
he main objective: to eliminate
nﬂammatory cancer
hen  faced  with  the  clinical  symptoms  of  breast  inﬂamma-
ion,  the  main  objective  is  to  eliminate  inﬂammatory  cancer.
ercutaneous  biopsies  play  a  large  part  in  eliminating  this
iagnosis,  given  the  limitations  of  imaging.
he limitations of imaging
hen  faced  with  inﬂammatory  symptoms,  the  main  ele-
ents  pointing  towards  inﬂammatory  cancer  are  the
resence  of  a  mass,  of  grouped  microcalciﬁcations  and  of
uspect  lymph  nodes.
A suspect  mass  in  imaging  is  a  strong  reason  supporting
nﬂammatory  cancer.  However,  there  may  be  no  mass,  and
nyway,  it  will  not  be  speciﬁc.  In  the  largest  study  published
n  inﬂammatory  breast  cancers,  involving  142  cases  [14], a
ass  was  clinically  palpable  in  62%  of  patients,  and  its  indi-
idual  characteristics  could  be  seen  on  the  mammogram  in
6%  of  patients  and  by  ultrasonography  in  80%  of  the  cases.
n  a more  recent  study  [15]  comparing  mammography,  ultra-
onography,  MRI  and  PET-TC  in  inﬂammatory  cancer,  a  mass
as  found  in  80%  of  patients  by  mammography,  in  95%  by
ltrasound,  in  96%  by  PET-TC  and  in  100%  of  the  patients  by
RI.  In  practice,  the  absence  of  a  mass  in  imaging  exami-
ations,  and  in  particular  with  ultrasound  (the  examination
o  perform  as  a  ﬁrst  course  of  action)  is  a  strong  argument
gainst  inﬂammatory  cancer  but  does  not,  nevertheless,
liminate  it.  On  the  other  hand,  the  presence  of  a  mass
ay  be  encountered  in  other  infectious,  and  particularly
nﬂammatory  diseases.  In  infectious  mastitis  complicated
y  an  abscess,  the  anechoic  character  of  the  contents  of
he  mass  and  the  individualisation  of  a  thick  wall  provide
ointers.  In  inﬂammatory  mastitis,  differential  diagnosis  is
till  very  difﬁcult,  since  a  mass  is  frequently  encountered:
t  is  one  of  the  diagnostic  criteria  for  diabetic  mastopathy
Fig.  2).  In  the  series  of  54  cases  of  granulomatous  lobular
120  E.  Bouic-Pagès  et  al.
Figure 2. Insulin-dependent diabetic patient aged 37, with no personal or family history of breast risk. Superior left, junctional, palpable,
hard, mobile, sensitive mass of recent appearance. Ultrasound-guided microbiopsy showed a diabetic mastopathy. a: left mammogram,
CC; b: left mammogram, lateral-medial oblique. Area of superior left, junctional, architectural distortion (arrow); c: ultrasound image:
superior left, junctional, attenuating, poorly circumscribed, hypoechoic mass; d: MRI: axial T2 TSE; e: MRI: axial T1EG, subtraction at the
third minute. Intermediate T2 signal spiculated mass (arrow) taking up contrast; f: perivascular (V) and perilobular (L) lymphocytic inﬁltrate
(arrow) associated with dense collagen ﬁbrosis (F).
a
m
u
t
w
r
c
7
m
o
I
E
i
i
w
r
p
b
B
a
•
•
•Percutaneous  biopsies:  Indications  and  techniques  
mastitis  [7],  a  mass  was  individualised  with  ultrasound  in
92%  of  patients,  whether  it  was  large  with  many  tubular
extensions,  or  irregular  and  hypoechoic,  highly  suggestive
of  cancer,  or  a  non-speciﬁc  mass.  In  mammography,  asym-
metric  density  is  found  more  often  than  a  mass  (Fig.  3).
Besides,  while  it  provides  a  pointer,  the  presence  of  a  mass
does  not  conﬁrm  the  diagnosis  of  inﬂammatory  cancer.
In  this  context  of  inﬂammatory  breast  cancer,  microcal-
ciﬁcations  are  present  in  half  of  the  patients  (in  49%  of  cases
in  Tardivon’s  series  of  92  patients  [11]  and  in  56%  of  cases
in  Günhan-Bilgen’s  series  of  142  patients  [14]). It  should  be
noted  that  10%  of  these  microcalciﬁcations  associated  with
an  inﬂammatory  cancer  appeared  as  benign  microcalciﬁca-
tions  in  both  the  series  mentioned  above.
Affected  lymph  nodes  are  frequently  present  in  inﬂam-
matory  cancers  [8].  Clinical  examination  and  ultrasonogra-
phy  are  better  for  identifying  them  than  mammography.
Affected  lymph  nodes  were  found  in  73%  of  the  cases  in
Günhan-Bilgen’s  series  [14]  and  in  93%  of  cases  in  a  series
published  more  recently  of  76  patients  [15]. An  important
fact  is  that  these  lymph  nodes  are  not  limited  to  the  axil-
lary  region  and  an  ultrasound  examination  may  ﬁnd  them
in  the  subclavicular,  supraclavicular  or  parasternal  nodes.
Even  though  rarer,  there  may  also  be  lymph  node  changes
in  an  infectious  or  inﬂammatory  disease.  For  example,  in
granulomatous  lobular  mastitis,  lymph  nodes  were  individu-
alised  by  ultrasound  in  28%  of  patients  [7].  The  presence  of
affected  lymph  nodes,  particularly  when  they  are  not  lim-
ited  to  the  axillary  region,  is  a  strong  reason  for  suspecting
an  inﬂammatory  cancer  in  an  inﬂammatory  context;  they  do
not  nevertheless  conﬁrm  the  diagnosis,  just  as  the  absence
of  affected  lymph  nodes  does  not  mean  this  diagnosis  can
be  eliminated.
Because  of  the  difﬁculties  encountered  by  clinical  exam-
ination,  mammography  and  ultrasonography,  MRI  has  been
evaluated  for  differentiating  between  inﬂammatory  cancer
•
Figure 3. Patient aged 55, with no personal or family history of breast r
as increased right retroareolar density. a: right CC; b: left CC; c: right late
try with increased right retroareolar density (arrow). Microbiopsy of hyp
granulomatous mastitis lesions.121
nd  acute  infectious  mastitis  [16]. In  inﬂammatory  cancers,
asses  were  more  common  and  more  numerous.  Their  vol-
me  was  greater,  there  was  more  frequent  inﬁltration  of
he  pectoral  muscle  and  they  were  more  often  deep-seated,
hile  acute  mastitis  lesions  were  more  often  subareolar.  A
ecent  publication  on  the  MRI  appearance  of  inﬂammatory
ancers  shows  that  these  lesions  are  often  multicentric  (in
7%  of  cases),  that  lymph  nodes  were  identiﬁed  in  MRI  in  the
ajority  of  cases  (83%),  that  the  margins  of  the  masses  were
ften  irregular,  and  that  their  kinetics  are  explosive  [17].
ndications and non-indications for biopsies
ven  if  a  reasoned  programme  including  a  clinical  exam-
nation,  a  mammogram  and  an  ultrasound  examination  is
mportant  in  managing  breast  inﬂammation,  there  is  still  a
ide  spectrum  of  indications  for  taking  tissue  samples.  This
easoning  was  well  developed  in  the  Egyptian  study,  which
roposed  a  step-by-step  approach  to  diagnosing  the  inﬂamed
reast  [2],  an  approach  which,  in  the  written  update  by  De
azelaire,  has  recently  been  summarised  in  the  following
xioms  [3]:
inﬂammatory  breast  symptoms  are  more  often  found  in
inﬂammatory  cancers  and  infectious  mastitis  than  in  non-
infectious  mastitis;
the presence  of  a  mass  or  a suspect  adenopathy  should
help  eliminate  an  infectious  origin  but  not  non-infectious
mastitis;
in  the  absence  of  a  suspect  adenopathy,  abscesses  and
their  contents  help  to  eliminate  inﬂammatory  cancer  and
non-infectious  mastitis  and  to  conﬁrm  an  infectious  origin
for  the  inﬂammatory  symptoms;
a  mass  associated  with  microcalciﬁcations  very  much  sup-
ports  inﬂammatory  cancer;  it  must  be  remembered  that
microcalciﬁcations  in  inﬂammatory  cancer  may  appear
benign  or  undetermined;
isk. Right palpable retroareolar mass appearing in the mammogram
ral-medial oblique; d: left lateral-medial oblique. Density asymme-
erechoic retroareolar mass under ultrasound showed inﬂammatory
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increased  density  and  thickened  skin  seem  to  be  observed
more  often  in  inﬂammatory  cancers  that  in  other  forms  of
mastitis;
This  reasoning  is  still  probabilistic,  and  in  clinical  practice
here  are  still  many  indications  for  biopsies.  Rather  than
eﬁne  these  indications,  we  will  deﬁne  the  non-indications:
clinical  symptoms  of  infectious  mastitis  with  no  suspect
lymph  nodes,  responding  well  to  medical  treatment,  with-
out  recurrence  of  the  symptoms;
mammary  abscess  without  suspect  lymph  nodes,  for  which
the  indication  is  not  a  microbiopsy  to  eliminate  an  inﬂam-
matory  cancer  but  ultrasound-guided  puncture,  ﬁrstly  for
therapeutic  evacuation  and  secondly,  so  as  to  determine
the  microorganism;
the  characteristic  appearance,  on  the  centred  mammo-
gram,  of  periductal  mastitis  with  thick,  linear,  branched,
microcalciﬁcations  with  a  clear  centre;
postoperative  cytosteatonecrosis,  unless  there  has  been
a  free  interval  and  the  clinical  symptoms  have  recurred
after  surgery.
In  other  cases,  biopsy  is  recommended  (Fig.  4).
uidance method and method for taking
iopsies
he  guidance  method  and  the  needles  used  for  biopsy
epend  on  the  target  from  which  the  sample  is  to  be
btained.  When  it  is  a  mass,  the  biopsy  will  be  performed
sing  ultrasound  with  a  Tru-cut  14G  needle.  A  lymph  node
iopsy  (which  must  always  be  performed  even  if  samples
ave  also  been  taken  from  a  breast  mass)  may  be  performed
ither  with  an  18G  needle  with  a  Tru-cut  type  system,  or  by
NAC,  bearing  in  mind  that  the  presence  of  inﬂammatory
ells  may  lead  to  a  false-positive.  In  our  practice,  we  pre-
er  in  this  context  to  perform  microbiopsies  on  the  lymph
odes.  When  microcalciﬁcations  are  concerned,  the  sam-
le  is  taken  by  stereotactic  microbiopsy,  remembering  that
hese  microcalciﬁcations  may  appear  benign.  When  there  is
ny  area  of  microcalciﬁcations  within  inﬂammatory  plaque,
 macrobiopsy  is  indicated.
Finally,  in  the  inﬂamed  breast  with  suspected  inﬂamma-
ory  cancer,  a  skin  microbiopsy  is  recommended  to  show
ny  possible  dermal  lymphatic  emboli  which,  even  if  they
o  not  provide  an  absolute  diagnostic  criterion,  have  diag-
ostic  and  prognostic  value.  The  consensus  conference  [10]
ecommended  taking  these  samples  from  areas  where  skin
olour  modiﬁcation  is  most  distinct.  These  biopsies  are  per-
ormed  with  a  2  to  8  mm  diameter  punch  pushed  in  vertically
ith  a  rotational  movement.  A  carrot  recovered  with  forceps
s  sectioned  at  the  bottom  with  a  scalpel.  The  biopsy  site
s  compressed  manually,  with  a  Steri-strip  applied  so  as  to
ring  the  edges  together,  and  is  covered  with  a  waterproof
ressing  to  be  kept  in  place  for  2  days.  This  biopsy  is  doubly
seful:  in  certain  cases  it  permits  inﬂammatory  cancer  to
e  diagnosed  when  the  breast  and/or  lymph  node  biopsies
re  negative,  and  it  is  also  useful  for  making  a  prognosis,
ince  it  is  acknowledged  that  the  prognosis  for  an  inﬂamma-
ory  breast  cancer  with  a  positive  skin  biopsy  is  poorer  than
or  an  inﬂammatory  breast  cancer  with  a  negative  biopsy
18].
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esults of the biopsy: characteristics of
nﬂammatory carcinomas
nﬂammatory  carcinoma  is  deﬁned  therefore  clinically  and
istologically  as  the  presence  of  an  invasive  cancer  in  the
ontext  of  breast  inﬂammation.  Histological  dermal  involve-
ent  is  a  classic  sign  (emboli)  but  it  is  not  essential  for  the
iagnosis.  The  notion  of  silent  inﬂammatory  cancer,  which
as  formerly  considered  to  be  a  form  of  inﬂammatory  can-
er  consisting  of  dermal  involvement  with  lymphatic  emboli
ut  without  signs  of  inﬂammation,  must  be  withdrawn.
Inﬂammatory  cancers  do  not  correspond  to  a  speciﬁc
istological  type  but  typically  have  the  histological  and
henotypic  characteristics  of  an  aggressive  tumour  [9,10].
sually  they  are  high-grade  inﬁltrating  ductal  carcinomas,
requently  accompanied  by  a  high-grade  in  situ  component
nd  superﬁcial  dermal  lymphatic  emboli  (Fig.  5).  They  are
ot  generally  hormone-dependent  and  are  characterised
y  a  high  proliferation  index,  and  usually  there  is  over-
xpression  of  the  HER2  protein  and  high  levels  of  EGF
eceptors,  indicating  strong  angiogenesis.  They  also  have  a
reater  rate  of  mutation  of  the  p53  protein,  which,  more-
ver,  is  a  factor  for  a  poor  prognosis  in  inﬂammatory  cancers.
n  the  other  hand,  the  same  proportion  is  found  of  inﬁltrat-
ng  ductal  carcinoma  versus  inﬁltrating  lobular  carcinoma  as
n  other  invasive  cancers.
he second objective: characterisation of
he  speciﬁc type of inﬂammatory or
nfectious mastitis
part  from  complicated  postoperative  cytosteatonecro-
is,  post-radiation  breasts  and  duct  ectasia  or  periductal
astitis,  inﬂammatory  mastitis  is  a  rare  cause  of  breast
nﬂammation,  found  most  frequently  due  to  a  palpable
ass.  Diagnosis  by  imaging  is  impossible  and  characterisa-
ion  of  the  mastitis  must  rely  on  the  biopsy.
on-speciﬁc imaging symptoms
n  these  types  of  mastitis,  masses  are  more  common
han  inﬂammatory  signs:  the  series  concerning  granuloma-
ous  lobular  mastitis  found  a  mass  in  more  than  90%  of
he  patients  [7].  The  cases  of  diabetic  mastitis  reported
19]  involved  often  mobile,  irregular,  poorly  circumscribed,
ainful  and  frequently  hard  masses,  which  were  often  bilat-
ral  but  can  be  single.  They  occur  particularly  in  young
atients  (mean  age  37  in  a  series  of  36  cases  published
ore  than  20  years  ago  [20]) and  individualising  the  mass  by
ammography  in  the  often  dense  breasts  is  difﬁcult.  Ultra-
ound  more  easily  detects  poorly  circumscribed  hypoechoic
asses  (Fig.  2c),  in  the  majority  of  cases  with  characteristic
igniﬁcant  posterior  attenuation.
Mastitis  related  to  other  even  more  unusual  immuno-
ogical  causes  has  no  speciﬁc  features  in  clinical,  mammo-
raphic  or  ultrasound  examinations  of  the  breast.  Lymph
ode  changes  are  rarer  than  in  infectious  mastitis  or  inﬂam-
atory  cancer,  but  are  still  possible.  Given  this  failure  as
egards  clinical  examination  and  imaging  of  the  breast,  evi-
ence  for  diagnosis  must  be  based  on  the  medical  history,
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Figure 4. Patient aged 55, with no personal or family history of breast risk. Right retroareolar induration and a certain amount of recurring
right nipple discharge. No abnormality on mammogram or ultrasound image. Macrobiopsy under MRI of right retroareolar ductal non-mass
enhancement showed inﬂammatory duct ectasia lesions. a: right mammogram CC; b: right mammogram, lateral-medial oblique; a—b: no
rod-like linear calciﬁcation; c: breast MRI: axial T1 EG, subtraction at the third minute: retroareolar duct enhancement (arrow); d: distended
milk duct, enclosing foamy histiocytes, surrounded by an inﬂammatory inﬁltrate.
Figure 5. Carcinomatous mastitis. a: inﬁltration of the dermis by a poorly differentiated ductal carcinoma; b: lymphatic emboli (EL).
124  
the  associated  clinical  symptoms  and  for  the  most  part,  on
the  biopsy.
The role of  associated clinical signs
In  the  rare  forms  of  inﬂammatory  mastitis,  only  the  clini-
cal  context  gives  a  pointer  to  a  diagnosis.  The  clinical  signs
of  systemic  diseases  which  may  be  accompanied  (rarely  in
practice)  by  breast  involvement  do  not  come  within  the  ﬁeld
of  this  paper.
Indications and performing the biopsy taking
into account histopathological requirements
Biopsies  can  be  microbiopsies  or,  if  necessary,  macrobiop-
sies.  It  is  important  to  provide  a  pointer  to  the  diagnostic
request  from  the  clinical  context,  in  order  to  help  the  histol-
ogist  in  his  work.  If  a  speciﬁc  infectious  mastitis  is  suspected
(tuberculosis,  a  fungal  infection  for  which  the  symptoms  are
often  less  explosive  than  for  ordinary  infectious  mastitis),  it
is  equally  important  to  send  samples  for  bacteriological  and
mycological  examination.
Results of the biopsy
Several  types  of  lesion  can  be  identiﬁed  from  the  histological
sample.  These  may  be  acute  inﬂammatory  lesions,  granu-
lomatous  lesions,  or  indicate  lymphocytic  mastitis.  If  the
biopsy  sample  does  not  remove  the  doubt,  if  treatment  is
ineffective  or  if  episodes  recur,  surgery  may  be  required.
There  are  many  aetiologies  for  granulomatous  mastitis.
The  diagnosis  of  idiopathic  granulomatous  lobular  mastitis
is  by  elimination  and  can  only  be  made  after  having  elimi-
nated  an  infectious  cause,  particularly  tuberculosis  (Fig.  6).
Without  any  context,  additional  speciﬁc  staining  methods
will  be  systematically  used  to  identify  pathogenic  agents
(PAS,  Gomori  Grocott,  Ziehl-Neelsen,  etc.)  but  samples  for
bacteriology  are  often  more  useful  for  detecting  certain
microorganisms,  particularly  mycobacteria.  The  presence  of
Figure 6. Patient of African origin aged 45, HIV+, cervical,
thoracic, abdominal and pelvic polyadenomegaly. Right lateral junc-
tional mammary mass of 25 mm. Ultrasound-guided microbiopsy
showed breast tuberculosis. Epithelioid granuloma with giant cells
(CG) and necrosis (N).
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ecrotising  epithelioid  granulomas  with  giant  cells  strongly
uggests  tuberculosis,  but  the  diagnosis  is  only  conﬁrmed
hen  acid-alcohol  resistant  bacilli  are  found.
In  duct  ectasia,  where  the  clinical  and  radiological  pic-
ure  can  sometimes  be  worrying,  particularly  in  the  absence
f  bilateral,  retroareolar,  linear,  thick  microcalciﬁcations,
he  diagnostic  difﬁculty  is  having  sufﬁcient  evidence  to  elim-
nate  a  carcinoma,  hence  the  usefulness  of  having  good
amples  of  the  lesion,  generally  obtained  by  macrobiopsy.
hese  will  show  dilated  ducts  surrounded  by  an  inﬂammatory
heath  of  lymphocytes/plasma  cells  evolving  towards  ﬁbro-
is.  Duct  rupture  can  also  produce  a  granulomatous  reaction.
Lymphocytic  mastopathy,  or  sclerosing  lymphocytic  lob-
litis,  is  a  non-infectious  lesion  characterised  by  a  lympho-
ytic  (predominantly  b  type)  inﬂammatory  inﬁltrate  forming
round  the  lobules  and  vessels.  It  evolves  towards  collagen
clerosis  and  atrophy  of  the  lobules.  Where  there  is  a  known
iabetic  or  auto-immune  disease  (Hashimoto’s  thyroiditis,
jögren’s  syndrome,  systemic  lupus  erythematosus,  etc.)
iagnosis  is  less  problematical,  but  the  appearance  is  some-
imes  rather  non-speciﬁc,  particularly  in  microbiopsies.
he third objective: obtaining a
icroorganism from abscesses sampled
hen  faced  with  a  walled-off  breast  abscess  seen  with
ltrasound,  puncturing  with  an  18G  needle  serves  several
urposes:
it  conﬁrms  the  diagnosis  of  an  abscess  (by  evacuating  pus),
and  allows  the  microorganism  to  be  identiﬁed,  bearing  in
mind  that  staphylococcus  is  the  microorganism  most  fre-
quently  encountered  but  that  a  number  of  abscesses  are
of  polybacterial  origin,  involving  staphylococci,  strepto-
cocci  and  anaerobic  organisms;
it forms  the  ﬁrst  stage  of  treatment.
Generally  speaking,  the  simplest  and  least  aggressive
easures  are  recommended  for  these  breast  abscesses,  with
epeated  puncture  aspirations  preferred  over  percutaneous
rainage,  which  only  a  few  years  ago  replaced  surgical
rainage.  In  the  case  of  an  abscess  of  more  than  2  cm  in
iameter,  instillation/aspiration  of  isotonic  saline  is  recom-
ended,  continuing  until  the  liquid  becomes  clear.
When,  as  is  often  the  case,  the  wall  of  the  abscess  is
hick,  if  cultures  are  negative  and/or  the  symptoms  persist
r  recur,  you  should  not  hesitate  to  take  a  microbiopsy  of
he  wall  to  look  for  another  cause  (inﬂammatory  mastitis
nd,  particularly,  inﬂammatory  cancer).  Indeed,  inﬂamma-
ory  cancer  must  always  be  considered  when  the  symptoms
re  chronic  and  do  not  respond  to  antibiotics  and  aspira-
ion,  even  if  the  clinical  symptoms  and  ultrasound  indicate
n  abscess.  In  a  training  article  recently  published  in  Radio-
raphics  [1],  considering  20  studies  which  had  included  975
atients  with  suspected  breast  abscesses,  six  cases  (0.6%)  of
nﬂammatory  cancer  were  identiﬁed.
Generally  speaking,  following  an  abscess  there  should
e  at  least  a  clinical  examination  with  or  without  ultra-
onography  repeated  after  1  or  2  weeks.  If  there  has  been  a
linical  response,  if  the  abscess  did  not  occur  during  preg-
ancy  or  breast-feeding,  a  mammogram  could  be  performed
n  patients  over  the  age  of  35.  If  the  clinical  response  is
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incomplete,  the  ultrasound  examination  needs  to  be
repeated,  aspiration  begun  again  and  possibly  a  biopsy
should  be  performed  of  the  wall  of  the  supposed  abscess.
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